The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Identifying HAM‐A cutoffs for mild, moderate, and severe generalized anxiety disorder
Open accessAbstract
The aim of the current study was to identify and evaluate cutoffs for mild, moderate, and severe ranges of Hamilton Anxiety Rating Scale (HAM‐A) scores. Data were from a four‐week randomized trial of treatment for generalized anxiety disorder. Measures included the HAM‐A, SF‐36, Hospital Anxiety and Depression Scale (HADS), and Clinical Global Impressions of Severity (CGI‐S) scale. HAM‐A cutoffs were identified based on literature review, expert panel input, and MANOVA models. The optimal cutoff set was evaluated based on association with clinician CGI‐S ratings. The sample included 144 patients (56.3% female; 73.6% white; mean age = 35.7 years; mean baseline HAM‐A score = 23.7). The optimal HAM‐A score ranges were: mild anxiety = 8–14; moderate = 15–23; severe ≥ 24 (scores ≤ 7 were considered to represent no/minimal anxiety). Analysis of variance (ANOVA) models found statistically significant differences among these groups in the SF‐36 and HADS. The HAM‐A severity ranges closely corresponded to clinicians' CGI‐S ratings. The study represents the first step towards developing severity ranges for the HAM‐A. These cutoffs should be used with caution and validated in larger samples. If the proposed cutoffs are accepted for general use, they could make results more meaningful and interpretable for researchers, clinicians, and patients. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
(1998) · PubMed · Cited by 10,216
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Serlin, R. C., Mendoza, T. R., Nakamura, Y., Edwards, K. R., & Cleeland, C. S. (1995) · Pain · doi:10.1016/0304-3959(94)00178-h · Cited by 1,494
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90072-9 · Cited by 1,044 · cited 3×
“For example, the instrument may not sufficiently Copyright © 2010 John Wiley & Sons, Ltd 223 discriminate between symptoms of depression and anxiety (Maier et al., 1988; Riskind et al., 1987).”
BackgroundMethodCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Aben, I., Verhey, F., Lousberg, R., Lodder, J., & Honig, A. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.5.386 · Cited by 573
Shear, M. K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M. W., Pollack, M. H., Chandler, L., Williams, J., Ali, A., et al. (2001) · Depression and Anxiety · doi:10.1002/da.1033 · Cited by 483
Effectiveness of St John's Wort in Major Depression: A Randomized Controlled Trial
Shelton, R. C., Keller, M. B., Gelenberg, A., Dunner, D. L., Hirschfeld, R., Thase, M. E., Russell, J., Lydiard, R. B., Crits-Christoph, P., Gallop, R., et al. (2001) · JAMA · doi:10.1001/jama.285.15.1978 · Cited by 382
Jensen, M. P., Smith, D. G., Ehde, D. M., & Robinsin, L. R. (2001) · Pain · doi:10.1016/s0304-3959(00)00459-0 · Cited by 313
Multivariate Statistics in the Social Sciences: A Researcher's Guide.
Bingham, C., Marascuilo, L. A., & Levin, J. R. (1985) · Journal of the American Statistical Association · doi:10.2307/2288090 · Cited by 287
Rickels, K., Pollack, M. H., Feltner, D. E., Lydiard, R. B., Zimbroff, D. L., Bielski, R. J., Tobias, K., Brock, J. D., Zornberg, G. L., & Pande, A. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.1022 · Cited by 280
Self-citationTaking the Measure of Anxiety and Depression Validity of the Reconstructed Hamilton Scales
RISKIND, J. H., BECK, A. T., BROWN, G., & STEER, R. A. (1987) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198708000-00005 · Cited by 270
Venlafaxine Extended-Release: A Review of its Use in the Management of Major Depression
Wellington, K., & Perry, C. M. (2001) · CNS Drugs · doi:10.2165/00023210-200115080-00007 · Cited by 263
Gulseren, S., Gulseren, L., Hekimsoy, Z., Cetinay, P., Ozen, C., & Tokatlioglu, B. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.05.008 · Cited by 251
Zelman, D. C., Dukes, E., Brandenburg, N., Bostrom, A., & Gore, M. (2005) · Pain · doi:10.1016/j.pain.2005.01.028 · Cited by 236
Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints
Paul, S. M., Zelman, D. C., Smith, M., & Miaskowski, C. (2005) · Pain · doi:10.1016/j.pain.2004.09.014 · Cited by 224
Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study
Rickels, K., Zaninelli, R., McCafferty, J., Bellew, K., Iyengar, M., & Sheehan, D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.749 · Cited by 198
Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
Sheehan, D. V. (2001) · PubMed · Cited by 187
Reliability and Validity of the Hamilton Anxiety Rating Scale in an Adolescent Sample
CLARK, D. B., & DONOVAN, J. E. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199403000-00009 · Cited by 159
Efficacy of Sertraline in a 12-Week Trial for Generalized Anxiety Disorder
Allgulander, C., Dahl, A. A., Austin, C., Morris, P., Søgaard, J., Fayyad, R. S., Kutcher, S., & Clary, C. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1642 · Cited by 149
Zelman, D. C., Hoffman, D. L., Seifeldin, R., & Dukes, E. M. (2003) · Pain · doi:10.1016/s0304-3959(03)00274-4 · Cited by 143
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
Llorca, P., Spadone, C., Sol, O., Danniau, A., Bougerol, T., Corruble, E., Faruch, M., Macher, J.-P., Sermet, É., & Servant, D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1112 · Cited by 141
Lenze, E. J., Mulsant, B. H., Shear, M. K., Dew, M. A., Miller, M. D., Pollock, B. G., Houck, P., Tracey, B., & Reynolds, C. F. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.146 · Cited by 135
Open-Label Trial of Riluzole in Generalized Anxiety Disorder
Mathew, S. J., Amiel, J. M., Coplan, J. D., Fitterling, H. A., Sackeïm, H. A., & Gorman, J. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2379 · Cited by 134
Smeraldi, E. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00139-0 · Cited by 104
Musselman, D. L., Somerset, W. I., Guo, Y., Manatunga, A. K., Porter, M. R., Penna, S., Lewison, B., Goodkin, R. S., Lawson, K. C., Lawson, D. H., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0217 · Cited by 93
Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale
Möller, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf03035121 · Cited by 83
Is the Cutoff to Define Remission on the Hamilton Rating Scale for Depression Too High?
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2005) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000154840.63529.5d · Cited by 79
Montgomery, S., Sheehan, D. V., Meoni, P., Haudiquet, V., & Hackett, D. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00005-5 · Cited by 71
Zimmerman, M. A., Posternak, M. A., & Chelminski, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000130232.57629.46 · Cited by 68
Lenox‐Smith, A., & Reynolds, A. (2003) · Europe PMC (PubMed Central) · Cited by 58
Safety and Efficacy of Escitalopram in the Long-Term Treatment of Generalized Anxiety Disorder
Davidson, J. R. T., Bose, A., & Wang, Q. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1115 · Cited by 44
The Assessment of Changes in Anxiety in a Drug Trial: A Comparison of Methods
Kellner, R., Kelly, A. V., & SHEFFIELD, B. F. (1968) · The British Journal of Psychiatry · doi:10.1192/bjp.114.512.863 · Cited by 37
Pollack, M. H., Rapaport, M. H., Fayyad, R. S., Otto, M. W., Nierenberg, A. A., & Clary, C. M. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00010-9 · Cited by 33
Bech, P., Grosby, H., Husum, B., & Rafaelsen, L. (2010) · Psychopathology · doi:10.1159/000284060 · Cited by 28
The Efficacy of Divalproex Sodium in the Treatment of Agitation Associated With Major Depression
DeBattista, C., Solomon, A., Arnow, B. A., et al. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000177552.21338.b0 · Cited by 28
Naukkarinen, H., Raassina, R., Penttinen, J., Ahokas, A., Jokinen, R., Koponen, H., Lepola, U. M., Kanerva, H., Lehtonen, L., Pohjalainen, T., et al. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.03.002 · Cited by 22
Estimation of symptom-free days in generalized anxiety disorder
Wan, G. J., Zhang, H. F., Tedeschi, M., & Hackett, D. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x96245 · Cited by 12
Tools for Assessing Generalized Anxiety Disorder
Belzer, K. D., & Schneier, F. R. (2006) · Cited by 5
Cited by
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
“Point estimates and bias-corrected 95% confidence intervals for the indirect effects of the mediation analysis were: meaningfulness (1.43 [0.72–2.44]), spiritual significance (1.19 [0.59– 2.10]), life satisfaction (0.60 [0.218–1.19]), HADS Anxiety (−1.50 [−3.50 to −0.33]), HADS Depression (−1.11 [−2.79 to −0.02]), HAD…”
MethodInfluentialKurokawa, S., Kishimoto, T., Mizuno, S., Masaoka, T., Naganuma, M., Liang, K.-C., Kitazawa, M., Nakashima, M., Shindo, C., Suda, W., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.038 · Cited by 205
Zuranolone for the Treatment of Postpartum Depression
Deligiannidis, K. M., Meltzer-Brody, S., Maximos, B., Peeper, E. Q., Freeman, M., Lasser, R., Bullock, A., Kotecha, M., Li, S., Forrestal, F., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220785 · Cited by 192
Clinical Utility of the Inventory of Depression and Anxiety Symptoms (IDAS)
Stasik-O’Brien, S. M., Brock, R. L., Chmielewski, M., Naragon-Gainey, K., Koffel, E., McDade-Montez, E., O’Hara, M. W., & Watson, D. (2019) · Assessment · doi:10.1177/1073191118790036 · Cited by 106
MahmoudianDehkordi, S., Bhattacharyya, S., Brydges, C. R., Jia, W., Fiehn, O., Rush, A. J., Dunlop, B. W., & Kaddurah-Daouk, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.937906 · Cited by 75
Metadata
- Authors
- Matza, L. S., Morlock, R., Sexton, C., Malley, K., & Feltner, D.
- Venue
- International Journal of Methods in Psychiatric Research
- Publisher
- Wiley
- Published
- 2010-08-18
- Volume
- 19
- Issue
- 4
- Pages
- 223-232
- ISSN
- 1049-8931 (ISSN-L)
- 1557-0657
- OpenAlex
- W1992694138
- Cited by
- 269
- References
- 46
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.